BioRestorative Therapies, Inc.·4

Oct 12, 2:01 PM ET

Silva Francisco 4

4 · BioRestorative Therapies, Inc. · Filed Oct 12, 2022

Insider Transaction Report

Form 4
Period: 2022-10-12
Silva Francisco
VP of Research and Development
Transactions
  • Purchase

    Common Stock

    2022-10-12$3.39/sh+725$2,457165,103 total
Holdings
  • Common Stock

    (indirect: By IRA)
    12,136
  • Stock Option

    Exercise: $3000.00Exp: 2024-02-18Common Stock (3 underlying)
    3
  • Stock Option

    Exercise: $3000.00Exp: 2025-09-04Common Stock (6 underlying)
    6
  • Stock Option

    Exercise: $3000.00Exp: 2028-10-29Common Stock (25 underlying)
    25
  • Stock Option

    Exercise: $3000.00Exp: 2022-12-07Common Stock (1 underlying)
    1
  • Stock Option

    Exercise: $3000.00Exp: 2027-07-12Common Stock (20 underlying)
    20
  • Stock Option

    Exercise: $3000.00Exp: 2024-10-23Common Stock (9 underlying)
    9
  • Stock Option

    Exercise: $13.50Exp: 2031-03-18Common Stock (293,479 underlying)
    293,479
  • Stock Option

    Exercise: $3000.00Exp: 2023-10-04Common Stock (1 underlying)
    1
  • Stock Option

    Exercise: $3000.00From: 2014-03-12Exp: 2024-03-11Common Stock (1 underlying)
    1
  • Stock Option

    Exercise: $3000.00Exp: 2026-06-10Common Stock (15 underlying)
    15
  • Stock Option

    Exercise: $13.50Exp: 2031-11-04Common Stock (42,059 underlying)
    42,059
Footnotes (4)
  • [F1]Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on each of November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
  • [F2]The option is currently exercisable.
  • [F3]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
  • [F4]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4